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Summary {#efs25471-sec-0001}
=======

In 2014, when the European Food Safety Authority (EFSA) reviewed the existing maximum residue levels (MRLs) for kresoxim‐methyl according to Article 12 of Regulation (EC) No 396/2005, EFSA identified some information as unavailable (data gaps) and derived tentative MRLs for those uses which were not fully supported by data but for which no risk to consumers was identified. The following data gaps were noted: further information on the occurrence of metabolites BF 490‐2 and BF 490‐9 in oranges, grapefruit and pome fruits resulting from the CXLs in these commodities;four residue trials on apricots and four residue trials on peaches supporting the southern outdoor uses on apricots and peaches;four residue trials supporting the northern outdoor use on beet leaves (chard);a study investigating the storage stability of the relevant residue for risk assessment (sum of the metabolites BF 490‐1, BF 490‐2 and BF 490‐9, expressed as parent) in milk, muscle, fat, liver and kidney, covering the storage conditions of the ruminants feeding study.

Tentative MRL proposals have been implemented in the MRL legislation by Commission Regulation (EU) No 2015/1200, including a footnote related to data gap number 4 indicating the type of confirmatory data that should be provided by a party having an interest in maintaining the proposed tentative MRL by 23 July 2017. Data gaps number 2 and 3 were not implemented in the MRL Regulation since risk managers decided to lower the MRLs in stone fruits and chards/beet leaves (data gaps 2 and 3) to the limit of quantification (LOQ) considering that the use of kresoxim‐methyl in those crops is not supported by any data. Also, data gap number 1 was not taken over in the MRL legislation; the CXLs for oranges, grapefruit and pome fruit were established as definitive MRLs without requesting confirmatory data.

To address the data gap number 4, the applicant provided a new storage stability study for commodities of animal origin covering a storage period of 15 months, to demonstrate validity of the feeding study in ruminants.

The summary table below provides an overview of the assessment of confirmatory data and the recommended modifications in the Regulation (EU) No 396/2005: Code[a](#efs25471-note-0005){ref-type="fn"}CommodityExisting MRL[b](#efs25471-note-0006){ref-type="fn"}Proposed MRLConclusion/recommendation**Enforcement residue definition for animal products** (milk): Metabolite BF 490‐9 (2‐\[2‐(4‐hydroxy‐2‐methylphenoxymethyl)phenyl\]‐2‐methoxy‐iminoacetic acid) expressed as kresoxim‐methyl **Enforcement residue definition for animal products** (others than milk and except for honey): Metabolite BF 490‐1 ((*E*)‐methoxyamino(α‐(*o*‐tolyloxy)‐otolyl\] acetic acid), expressed as kresoxim‐methyl[c](#efs25471-note-0007){ref-type="fn"}1011010Swine Muscle0.05[\*](#efs25471-note-0008){ref-type="fn"} [ft](#efs25471-note-0009){ref-type="fn"}0.05[\*](#efs25471-note-0008){ref-type="fn"}A new storage stability study demonstrates that residues of kresoxim‐methyl and its metabolites included in the residue definition for risk assessment (i.e. BF 490‐1, BF 490‐2 and BF 490‐9) are stable in animal origin commodities for 15 months The submitted study is sufficiently addressing the data gap identified in the MRL review. Thus, the footnote in the MRL Regulation can be removed The previously derived MRLs are still valid. The new information does not require a revision of the previously performed risk assessment for kresoxim‐methyl1011020Swine Fat0.05[\*](#efs25471-note-0008){ref-type="fn"} [ft](#efs25471-note-0009){ref-type="fn"}0.05[\*](#efs25471-note-0008){ref-type="fn"}1011030Swine Liver0.05[\*](#efs25471-note-0008){ref-type="fn"} [ft](#efs25471-note-0009){ref-type="fn"}0.05[\*](#efs25471-note-0008){ref-type="fn"}1011040Swine Kidney0.05[\*](#efs25471-note-0008){ref-type="fn"} [ft](#efs25471-note-0009){ref-type="fn"}0.05[\*](#efs25471-note-0008){ref-type="fn"}1012010Bovine Muscle0.05[\*](#efs25471-note-0008){ref-type="fn"} [ft](#efs25471-note-0009){ref-type="fn"}0.05[\*](#efs25471-note-0008){ref-type="fn"}1012020Bovine Fat0.05[\*](#efs25471-note-0008){ref-type="fn"} [ft](#efs25471-note-0009){ref-type="fn"}0.05[\*](#efs25471-note-0008){ref-type="fn"}1012030Bovine Liver0.05[\*](#efs25471-note-0008){ref-type="fn"} [ft](#efs25471-note-0009){ref-type="fn"}0.05[\*](#efs25471-note-0008){ref-type="fn"}1012040Bovine Kidney0.05[\*](#efs25471-note-0008){ref-type="fn"} [ft](#efs25471-note-0009){ref-type="fn"}0.05[\*](#efs25471-note-0008){ref-type="fn"}1013010Sheep Muscle0.05[\*](#efs25471-note-0008){ref-type="fn"} [ft](#efs25471-note-0009){ref-type="fn"}0.05[\*](#efs25471-note-0008){ref-type="fn"}1013020Sheep Fat0.05[\*](#efs25471-note-0008){ref-type="fn"} [ft](#efs25471-note-0009){ref-type="fn"}0.05[\*](#efs25471-note-0008){ref-type="fn"}1013030Sheep Liver0.05[\*](#efs25471-note-0008){ref-type="fn"} [ft](#efs25471-note-0009){ref-type="fn"}0.05[\*](#efs25471-note-0008){ref-type="fn"}1013040Sheep Kidney0.05[\*](#efs25471-note-0008){ref-type="fn"} [ft](#efs25471-note-0009){ref-type="fn"}0.05[\*](#efs25471-note-0008){ref-type="fn"}1014010Goat Muscle0.05[\*](#efs25471-note-0008){ref-type="fn"} [ft](#efs25471-note-0009){ref-type="fn"}0.05[\*](#efs25471-note-0008){ref-type="fn"}1014020Goat Fat0.05[\*](#efs25471-note-0008){ref-type="fn"} [ft](#efs25471-note-0009){ref-type="fn"}0.05[\*](#efs25471-note-0008){ref-type="fn"}1014030Goat Liver0.05[\*](#efs25471-note-0008){ref-type="fn"} [ft](#efs25471-note-0009){ref-type="fn"}0.05[\*](#efs25471-note-0008){ref-type="fn"}1014040Goat Kidney0.05[\*](#efs25471-note-0008){ref-type="fn"} [ft](#efs25471-note-0009){ref-type="fn"}0.05[\*](#efs25471-note-0008){ref-type="fn"}1020010Milk Cattle0.01[\*](#efs25471-note-0008){ref-type="fn"} [ft](#efs25471-note-0009){ref-type="fn"}0.01[\*](#efs25471-note-0008){ref-type="fn"}1020020Milk Sheep0.01[\*](#efs25471-note-0008){ref-type="fn"} [ft](#efs25471-note-0009){ref-type="fn"}0.01[\*](#efs25471-note-0008){ref-type="fn"}1020030Milk Goat0.01[\*](#efs25471-note-0008){ref-type="fn"} [ft](#efs25471-note-0009){ref-type="fn"}0.01[\*](#efs25471-note-0008){ref-type="fn"}[^1][^2][^3][^4][^5][^6]

Assessment {#efs25471-sec-0003}
==========

The review of existing maximum residue levels (MRLs) for the active substance kresoxim‐methyl according to Article 12 of Regulation (EC) No 396/2005[1](#efs25471-note-1004){ref-type="fn"} (MRL review) has been performed in 2014 (EFSA, [2014](#efs25471-bib-0003){ref-type="ref"}). The European Food Safety Authority (EFSA) identified some information as unavailable (data gaps) and derived tentative MRLs for those uses not fully supported by data but for which no risk to consumers was identified. The following data gaps were noted: further information on the occurrence of metabolites BF 490‐2 and BF 490‐9 in oranges, grapefruit and pome fruits resulting from the CXLs in these commodities;four residue trials on apricots and four residue trials on peaches supporting the southern outdoor uses on apricots and peaches;four residue trials supporting the northern outdoor use on beet leaves (chard);a study investigating the storage stability of the relevant residue for risk assessment (sum of the metabolites BF 490‐1, BF 490‐2 and BF 490‐9, expressed as parent) in milk, muscle, fat, liver and kidney, covering the storage conditions of the ruminants feeding study.

Following the review of existing MRLs, the legal limits have been modified by Commission Regulation (EU) No 1127/2014[2](#efs25471-note-5002){ref-type="fn"}, including footnotes for tentative MRLs that specified the type of information that was identified as missing. It is noted that data gaps number 2 and 3 have not been implemented in the MRL legislation, since the uses have not been supported by any residue trial matching the Good Agricultural Practice (GAP) and therefore risk managers decided to lower the MRL to the limit of quantification (LOQ). Also, data gap number 1 was not taken over in the MRL legislation; the CXLs for oranges, grapefruit and pome fruit were established as definitive MRLs without requesting confirmatory data.

Any party having an interest in maintaining the proposed tentative MRL were requested to address the confirmatory data requirement by 23 July 2017.

In accordance with the specific provisions set out in the working document of the European Commission ([2016](#efs25471-bib-0005){ref-type="ref"}), the applicant, BASF SE, submitted an application to the competent national authority in Belgium (designated rapporteur Member State (RMS)) to evaluate the confirmatory data identified during the MRL review and for assessing the uses in peaches, apricots and chards that were lowered to the LOQ following the MRL review.

To address the data gap number (4) identified by EFSA, the applicant provided a new storage stability study in commodities of animal origin covering a storage period of 15 months to demonstrate the validity of the feeding study in ruminants that was used to derive the MRL proposals for commodities of animal origin.

The RMS assessed the new information in an evaluation report, which was submitted to the European Commission and forwarded to EFSA on 8 March 2018 (Belgium, [2018](#efs25471-bib-0001){ref-type="ref"}). EFSA assessed the application as requested by the European Commission in accordance with Article 9 of Regulation (EC) No 396/2005. It is noted that the original application received covered not only the confirmatory data, but also contained a request to modify the existing MRLs for apricots, peaches and beet leaves (EFSA‐Q‐2018‐00233). Since for this MRL application, EFSA identified points which needed further clarifications, a separate reasoned opinion will be issued by EFSA, once the requested information is provided.

EFSA based its assessment on the evaluation report submitted by the RMS (Belgium, [2018](#efs25471-bib-0001){ref-type="ref"}, [3](#efs25471-note-1005){ref-type="fn"}), the reasoned opinion on the MRL review according to Article 12 of Regulation (EC) No 396/2005 and an additional assessment of kresoxim‐methyl performed after the MRL review (EFSA, [2015](#efs25471-bib-0004){ref-type="ref"}).

For this application, the data requirements established in Regulation (EU) No 544/2011[4](#efs25471-note-1006){ref-type="fn"} and the relevant guidance documents at the date of implementation of the confirmatory data requirements by Regulation (EU) No 2015/1200 are applicable. The assessment is performed in accordance with the legal provisions of the Uniform Principles for the Evaluation and the Authorisation of Plant Protection Products adopted by Commission Regulation (EU) No 546/2011[5](#efs25471-note-5005){ref-type="fn"}.

An updated list of endpoints, including the endpoints of relevant in the framework of this confirmatory data, is presented in Appendix [B](#efs25471-sec-1002){ref-type="sec"}.

The evaluation report submitted by the RMS (Belgium, [2018](#efs25471-bib-0001){ref-type="ref"}) is considered a supporting document to this reasoned opinion and, thus, is made publicly available as a background document.

1. Residues in plants {#efs25471-sec-0004}
=====================

Not relevant for the current assessment.

The confirmatory data requirement for kresoxim‐methyl identified in Commission Regulation (EU) No 2015/1200 does not relate to residues in commodities of plant origin.

2. Residues in livestock {#efs25471-sec-0005}
========================

The MRLs derived during the MRL review for food of animal origin were proposed on tentative basis considering that the maximum storage time period for samples of milk, muscle, fat, liver and kidney of the ruminant feeding study were not covered by storage stability data for the metabolites BF 490‐1, BF 490‐2 and BF 490‐9. These metabolites are part of the proposed residue definition for risk assessment of animal origin commodities (EFSA, [2014](#efs25471-bib-0003){ref-type="ref"}).

EFSA asked to demonstrate the stability of BF 490‐1, BF 490‐2 and BF 490‐9 in animal tissues stored under freezer conditions for up to 175 days, in order to confirm the validity of the feeding study (EFSA, [2014](#efs25471-bib-0003){ref-type="ref"}). A footnote requesting the missing data related to this data gap was implemented by Commission Regulation (EU) No 2015/1200. This footnote applies to the MRLs for muscle, fat, kidney and liver of ruminants and swine and to the MRLs of ruminants' milk.

2.1. Nature of residues in livestock {#efs25471-sec-0006}
------------------------------------

An animal metabolism study in lactating goat was evaluated under the framework of the MRL review (EFSA, [2014](#efs25471-bib-0003){ref-type="ref"}) and during the peer‐review (EFSA, [2010](#efs25471-bib-0002){ref-type="ref"}). See Appendix [B](#efs25471-sec-1002){ref-type="sec"} for further information on the metabolism studies in livestock. The residue definition for risk assessment (ruminants/swine tissues and ruminants milk) was defined as: sum of the metabolites BF 490‐1, BF 490‐2 and BF 490‐9, expressed as parent (EFSA, [2014](#efs25471-bib-0003){ref-type="ref"}).

EFSA derived the following residue definition for monitoring for food commodities of animal origin (ruminants/swine tissues and ruminants milk (EFSA, [2014](#efs25471-bib-0003){ref-type="ref"}): Metabolite BF 490‐1, expressed as kresoxim‐methyl.

When implementing the MRL proposals derived in the MRL review, risk managers decided to set the following residue definition (Commission Regulation (EU) No 1127/2014): BF 490‐9, expressed as kresoxim‐methyl.

Later, the residue definition for monitoring of food commodities of animal origin was revised (Regulation (EC) No 2016/486)[6](#efs25471-note-1007){ref-type="fn"} as follows: --Metabolite BF 490‐1 for muscle, fat, liver and kidney expressed as kresoxim‐methyl.--Metabolite BF 490‐9 for milk expressed as kresoxim‐methyl.

2.2. Magnitude of residues in livestock {#efs25471-sec-0007}
---------------------------------------

Since the data submitted under the current application confirmed the validity of the feeding study (see Section [2.3](#efs25471-sec-0008){ref-type="sec"}), the MRLs and the risk assessment values for animal products (i.e. muscle, fat, liver and kidney of ruminants and swine for milk of ruminants milk) are confirmed.

2.3. Storage stability data on animal origin commodities {#efs25471-sec-0008}
--------------------------------------------------------

A study investigating the storage stability of the metabolites of kresoxim‐methyl (BF 490‐1, BF 490‐2 and BF 490‐9) has been submitted in order to fulfil the identified confirmatory data requirement for kresoxim‐methyl and was assessed by the RMS (Belgium, [2018](#efs25471-bib-0001){ref-type="ref"}).

The storage stability study was in compliance with the current OECD guideline 506 (OECD, [2007](#efs25471-bib-0006){ref-type="ref"}). In the study, residues were analysed in the different animal matrices (milk, fat, muscle, kidney and liver) which have been spiked with the metabolites at the level of 0.1 mg/kg after storage at −20°C for 0, 6, 12 and 15 months. The recoveries in the different tissues ranged from 84% to 108% compared to the fortification level.

According to the RMS, the data provided by the applicant are not complete, since the storage stability was not tested for all matrix/metabolite combinations: no data were provided for storage stability of BF 490‐9 in muscle, BF 490‐2 in liver and BF 490‐1 in milk. However, considering that according to the metabolism study assessed in the MRL review (see Table [1](#efs25471-tbl-0001){ref-type="table"}) residues in the matrix/metabolite combinations mentioned are not expected, EFSA is of the opinion that the submitted storage stability study is sufficient to address the data gap. It concluded that the metabolites BF 490‐1, BF 490‐2 and BF 490‐9 are stable for 15 months under frozen conditions in commodities of animal origin. Therefore, the feeding study used to derive the MRL proposals and the risk assessment values are valid.

###### 

Summary of the expected metabolites in the different animal tissues and the availability of storage stability data to confirm the suitability of the livestock feeding study for MRL setting in products of animal origin

  Animal tissue   Occurrence of major metabolites in animal matrices from the metabolism study in lactating goat (EFSA, [2014](#efs25471-bib-0003){ref-type="ref"}) expressed as %TRR   Time intervals for which storage stability was demonstrated   Recovery ranges in the storage stability study expressed in terms of % recovery of the nominal spiking level of 0.1 mg/kg (Belgium, [2018](#efs25471-bib-0001){ref-type="ref"})                                     
  --------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --- -------------- -------------- --------------
  Muscle          24                                                                                                                                                                    14                                                            --                                                                                                                                                                                0   100            100            Not analysed
  6               96                                                                                                                                                                    98                                                                                                                                                                                                                                                                                
  12              102                                                                                                                                                                   101                                                                                                                                                                                                                                                                               
  15              100                                                                                                                                                                   87                                                                                                                                                                                                                                                                                
  Fat             23                                                                                                                                                                    24                                                            --                                                                                                                                                                                0   100            100            100
  6               96                                                                                                                                                                    102                                                           114                                                                                                                                                                                                                 
  12              100                                                                                                                                                                   102                                                           107                                                                                                                                                                                                                 
  15              96                                                                                                                                                                    89                                                            101                                                                                                                                                                                                                 
  Kidney          22                                                                                                                                                                    34                                                            30                                                                                                                                                                                0   100            100            100
  6               108                                                                                                                                                                   98                                                            94                                                                                                                                                                                                                  
  12              86                                                                                                                                                                    94                                                            90                                                                                                                                                                                                                  
  15              89                                                                                                                                                                    95                                                            85                                                                                                                                                                                                                  
  Liver           13                                                                                                                                                                    --                                                            29                                                                                                                                                                                0   100            Not analysed   100
  6               93                                                                                                                                                                    105                                                                                                                                                                                                                                                                               
  12              89                                                                                                                                                                    103                                                                                                                                                                                                                                                                               
  15              87                                                                                                                                                                    99                                                                                                                                                                                                                                                                                
  Milk            --                                                                                                                                                                    --                                                            63                                                                                                                                                                                0   Not analysed   100            100
  6               86                                                                                                                                                                    88                                                                                                                                                                                                                                                                                
  12              84                                                                                                                                                                    95                                                                                                                                                                                                                                                                                
  15              86                                                                                                                                                                    97                                                                                                                                                                                                                                                                                

TRR: total radioactive residue.

John Wiley & Sons, Ltd

3. Consumer risk assessment {#efs25471-sec-0009}
===========================

There is no need to change the MRLs of animal origin commodities; the consumer risk assessment performed in the framework of the MRL review (EFSA, [2014](#efs25471-bib-0003){ref-type="ref"}) does not have to be revised.

4. Conclusion and Recommendations {#efs25471-sec-0010}
=================================

The data submitted in support of this application was sufficient to confirm the validity of the feeding study in ruminants which was the basis to derive the MRL proposals and risk assessment values for commodities of animal origin derived during the MRL review. The metabolites BF 490‐1, BF 490‐2 and BF 490‐9 were demonstrated to be stable for 15 months in ruminants and swine tissues (muscle, fat, liver, and kidney) and ruminants' milk.

The footnote in the MRL Regulation (Annex II), which refers to the confirmatory data submitted in the framework of the current assessment, can be removed.

Abbreviations {#efs25471-sec-0011}
=============

bwbody weightCXLCodex maximum residue limitGAPGood Agricultural PracticeGC‐ECDgas chromatography with electron capture detectorHPLC‐UVDhigh performance liquid chromatography with ultraviolet detectorInChiKeyInternational Chemical Identifier Key.ILVindependent laboratory validationLOQlimit of quantificationMRLmaximum residue levelOECDOrganisation for Economic Co‐operation and DevelopmentPRIMo(EFSA) Pesticide Residues Intake ModelRMSrapporteur Member StateSMILESsimplified molecular‐input line‐entry systemTRRtotal radioactive residue

Appendix A -- Summary of GAPs assessed in the evaluation of confirmatory data {#efs25471-sec-1001}
=============================================================================

 {#efs25471-sec-0012}

Not relevant for the current assessment.

Appendix B -- List of end points {#efs25471-sec-1002}
================================

B.1.. Residues in plants {#efs25471-sec-0013}
------------------------

Not relevant for the current assessment.

B.2.. Residues in livestock {#efs25471-sec-0014}
---------------------------

### B.2.1.. Nature of residues and methods of analysis in livestock {#efs25471-sec-0015}

#### B.2.1.1.. Metabolism studies, methods of analysis and residue definitions in livestock {#efs25471-sec-0016}

Livestock (available studies)AnimalDose (mg/kg bw per day)Duration (days)Comment/sourceLactating goatDosage by intubation (3 animals) Goat A: 0.25 Goat B: 25 Goat C: 25Goat A: 5 Goat B: 8 Goat C: 8Label position: ^14^C‐phenyl; ^13^C‐kresoxim‐methyl^(a)^ (a): Different ratios according to the goats: goat A, ^14^C/^13^C/unlabelled: 3/0/1; goat B, ^14^C/^13^C/unlabelled: 1/4/10; goat C, ^14^C/^13^C/unlabelled: 1/0/20 Sampling: milk, urine and faeces sampled daily; at sacrifice^(b)^: muscle, liver, kidney, fat (b): Sacrifice occurred within 24 h of the last administration (23 h for goat A, 4 h for goats B and C)Lactating goatBy oral gavage, once per day: 13.9 mg/kg in the diet5Label position: ^14^C‐phenoxy Sampling: milk (twice per day), urine and faeces daily and at sacrifice: liver, kidney, bile, rumen, gastrointestinal tract, muscle, fatLaying henDosage by oral gavage, once per day 1 (group 1: 5 hens); 19 (group 2:10 hens)6Label position: ^14^C‐phenyl; ^13^C‐kresoxim‐methyl^(c)^ (c): Different ratios according to the poultry groups: ratio ^14^C/unlabelled: 1/1 (group 1), ratio ^14^C/^13^C/unlabelled: 1/4/3 (group 2) Sampling: eggs, excreta daily; At sacrifice: muscle, liver, kidney, fat, skin, gastrointestinal tractPig------Fish------

![](EFS2-16-e05471-g001.jpg "image")

#### B.2.1.2.. Stability of residues in livestock {#efs25471-sec-0017}

Animal products (available studies)AnimalCommodityT (°C)Stability periodCompounds coveredComment/sourceValueUnitRuminantsMuscle[a](#efs25471-note-1008){ref-type="fn"}−1815MonthsBF 490‐1 BF 490‐2Belgium ([2018](#efs25471-bib-0001){ref-type="ref"})RuminantsFat−1815MonthsBF 490‐1 BF 490‐2BF 490‐9Belgium ([2018](#efs25471-bib-0001){ref-type="ref"})RuminantsLiver[a](#efs25471-note-1008){ref-type="fn"}−1815MonthsBF 490‐1 BF 490‐9Belgium ([2018](#efs25471-bib-0001){ref-type="ref"})RuminantsKidney−1815MonthsBF 490‐1 BF 490‐2 BF 490‐9Belgium ([2018](#efs25471-bib-0001){ref-type="ref"})RuminantsMilk[a](#efs25471-note-1008){ref-type="fn"}−1815MonthsBF 490‐2 BF 490‐9Belgium ([2018](#efs25471-bib-0001){ref-type="ref"})PoultryEggs----------[^7]

### B.2.2.. Magnitude of residues in livestock {#efs25471-sec-0018}

Not relevant for the current assessment.

B.3.. Consumer risk assessment {#efs25471-sec-0019}
------------------------------

The consumer risk assessment does not need to be updated, provided that the existing MRLs for products of animal origin remain unchanged.

B.4.. Recommended MRLs {#efs25471-sec-0020}
----------------------

Code[a](#efs25471-note-1011){ref-type="fn"}CommodityExisting MRL[b](#efs25471-note-1012){ref-type="fn"}Proposed MRLConclusion/recommendation**Enforcement residue definition for animal products** (milk): Metabolite BF 490‐9 (2‐\[2‐(4‐hydroxy‐2‐methylphenoxymethyl)phenyl\]‐2‐methoxy‐iminoacetic acid) expressed as kresoxim‐methyl **Enforcement residue definition for animal products** (others than milk and except for honey): Metabolite BF 490‐1 ((*E*)‐methoxyamino(α‐(*o*‐tolyloxy)‐otolyl\] acetic acid), expressed as kresoxim‐methyl[c](#efs25471-note-1013){ref-type="fn"}1011010Swine Muscle0.05[\*](#efs25471-note-1010){ref-type="fn"} [ft](#efs25471-note-1014){ref-type="fn"}0.05[\*](#efs25471-note-1010){ref-type="fn"}A new storage stability study demonstrates that residues of kresoxim‐methyl and its metabolites included in the residue definition for risk assessment (i.e. BF 490‐1, BF 490‐2 and BF 490‐9) are stable in animal origin commodities for 15 months The submitted study is sufficiently addressing the data gap identified in the MRL review. Thus, the footnote in the MRL Regulation can be removed The previously derived MRLs are still valid. The new information does not require a revision of the previously performed risk assessment for kresoxim‐methyl1011020Swine Fat0.05[\*](#efs25471-note-1010){ref-type="fn"} [ft](#efs25471-note-1014){ref-type="fn"}0.05[\*](#efs25471-note-1010){ref-type="fn"}1011030Swine Liver0.05[\*](#efs25471-note-1010){ref-type="fn"} [ft](#efs25471-note-1014){ref-type="fn"}0.05[\*](#efs25471-note-1010){ref-type="fn"}1011040Swine Kidney0.05[\*](#efs25471-note-1010){ref-type="fn"} [ft](#efs25471-note-1014){ref-type="fn"}0.05[\*](#efs25471-note-1010){ref-type="fn"}1012010Bovine Muscle0.05[\*](#efs25471-note-1010){ref-type="fn"} [ft](#efs25471-note-1014){ref-type="fn"}0.05[\*](#efs25471-note-1010){ref-type="fn"}1012020Bovine Fat0.05[\*](#efs25471-note-1010){ref-type="fn"} [ft](#efs25471-note-1014){ref-type="fn"}0.05[\*](#efs25471-note-1010){ref-type="fn"}1012030Bovine Liver0.05[\*](#efs25471-note-1010){ref-type="fn"} [ft](#efs25471-note-1014){ref-type="fn"}0.05[\*](#efs25471-note-1010){ref-type="fn"}1012040Bovine Kidney0.05[\*](#efs25471-note-1010){ref-type="fn"} [ft](#efs25471-note-1014){ref-type="fn"}0.05[\*](#efs25471-note-1010){ref-type="fn"}1013010Sheep Muscle0.05[\*](#efs25471-note-1010){ref-type="fn"} [ft](#efs25471-note-1014){ref-type="fn"}0.05[\*](#efs25471-note-1010){ref-type="fn"}1013020Sheep Fat0.05[\*](#efs25471-note-1010){ref-type="fn"} [ft](#efs25471-note-1014){ref-type="fn"}0.05[\*](#efs25471-note-1010){ref-type="fn"}1013030Sheep Liver0.05[\*](#efs25471-note-1010){ref-type="fn"} [ft](#efs25471-note-1014){ref-type="fn"}0.05[\*](#efs25471-note-1010){ref-type="fn"}1013040Sheep Kidney0.05[\*](#efs25471-note-1010){ref-type="fn"} [ft](#efs25471-note-1014){ref-type="fn"}0.05[\*](#efs25471-note-1010){ref-type="fn"}1014010Goat Muscle0.05[\*](#efs25471-note-1010){ref-type="fn"} [ft](#efs25471-note-1014){ref-type="fn"}0.05[\*](#efs25471-note-1010){ref-type="fn"}1014020Goat Fat0.05[\*](#efs25471-note-1010){ref-type="fn"} [ft](#efs25471-note-1014){ref-type="fn"}0.05[\*](#efs25471-note-1010){ref-type="fn"}1014030Goat Liver0.05[\*](#efs25471-note-1010){ref-type="fn"} [ft](#efs25471-note-1014){ref-type="fn"}0.05[\*](#efs25471-note-1010){ref-type="fn"}1014040Goat Kidney0.05[\*](#efs25471-note-1010){ref-type="fn"} [ft](#efs25471-note-1014){ref-type="fn"}0.05[\*](#efs25471-note-1010){ref-type="fn"}1020010Milk Cattle0.01[\*](#efs25471-note-1010){ref-type="fn"} [ft](#efs25471-note-1014){ref-type="fn"}0.01[\*](#efs25471-note-1010){ref-type="fn"}1020020Milk Sheep0.01[\*](#efs25471-note-1010){ref-type="fn"} [ft](#efs25471-note-1014){ref-type="fn"}0.01[\*](#efs25471-note-1010){ref-type="fn"}1020030Milk Goat0.01[\*](#efs25471-note-1010){ref-type="fn"} [ft](#efs25471-note-1014){ref-type="fn"}0.01[\*](#efs25471-note-1010){ref-type="fn"}[^8][^9][^10][^11][^12][^13]

Appendix C -- Pesticide Residue Intake Model (PRIMo) {#efs25471-sec-1003}
====================================================

 {#efs25471-sec-0021}

Not relevant for the current assessment.

Appendix D -- Input values for the exposure calculations {#efs25471-sec-1004}
========================================================

D.1. Livestock dietary burden calculations {#efs25471-sec-0022}
------------------------------------------

Not relevant for the current assessment.

D.2.. Consumer risk assessment {#efs25471-sec-0023}
------------------------------

Not relevant for the current assessment.

Appendix E -- Used compound codes {#efs25471-sec-1005}
=================================

 {#efs25471-sec-0024}

Code/trivial name[a](#efs25471-note-1016){ref-type="fn"}IUPAC name/SMILES notation/InChiKey[b](#efs25471-note-1017){ref-type="fn"}Structural formula[c](#efs25471-note-1018){ref-type="fn"}Kresoxim‐methylmethyl (*E*)‐methoxyimino\[α‐(*o*‐tolyloxy)‐*o*‐tolyl\]acetate O=C(OC)\\C(=N\\OC)c1ccccc1COc1ccccc1C ZOTBXTZVPHCKPN‐HTXNQAPBSA‐N![](EFS2-16-e05471-g002.jpg "image")BF 490‐1 (acid of kresoxim‐methyl)(*E*)‐methoxyamino(α‐(*o*‐tolyloxy)‐*o*‐tolyl\]acetic acid O=C(O)\\C(=N\\OC)c1ccccc1COc1ccccc1C LXOPDEDFRXZTNO‐FBMGVBCBSA‐N![](EFS2-16-e05471-g003.jpg "image")BF 490‐2(2*E*)‐(2‐{\[2‐(hydroxymethyl)phenoxy\]methyl}phenyl)(methoxyimino)acetic acid O=C(O)\\C(=N\\OC)c1ccccc1COc1ccccc1CO VYCKDLWRTQBZRB‐FBMGVBCBSA‐N![](EFS2-16-e05471-g004.jpg "image")BF 490‐9(2*E*)‐{2‐\[(4‐hydroxy‐2‐methylphenoxy)methyl\]phenyl}(methoxyimino)acetic acid O=C(O)\\C(=N\\OC)c1ccccc1COc1ccc(O)cc1C HEMVDCDJEKCCCZ‐FBMGVBCBSA‐N![](EFS2-16-e05471-g005.jpg "image")BF 490‐3methyl (2*E*)‐(hydroxyimino){2‐\[(2‐methylphenoxy)methyl\]phenyl}acetate O=C(OC)\\C(=N\\O)c1ccccc1COc1ccccc1C NNHDCYABCHZSQT‐FBMGVBCBSA‐N![](EFS2-16-e05471-g006.jpg "image")[^14][^15][^16][^17]

Regulation (EC) No 396/2005 of the Parliament and of the Council of 23 February 2005 on maximum residue levels of pesticides in or on food and feed of plant and animal origin and amending Council Directive 91/414/EEC. OJ L 70, 16.3.2005, p. 1--16.

Commission Regulation (EU) No 1127/2014 of 20 October 2014 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for amitrole, dinocap, fipronil, flufenacet, pendimethalin, propyzamide and pyridate in or on certain products. OJ L 305, 24.10.2014, p. 47--99.

It is noted that the evaluation report submitted in support of the application covered not only the confirmatory data, but also contained the assessment of data submitted in support of a request of the setting of MRLs for kresoxim‐methyl in stone fruits, apricot, peach and beet leaves (EFSA‐Q‐2018‐00233); this MRL application will be assessed in a separate reasoned opinion.

Commission Regulation (EU) No 544/2011 of 10 June 2011 implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards the data requirements for active substances. OJ L 155, 11.6.2011, p. 1--66.

Commission Regulation (EU) No 546/2011 of 10 June 2011 implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards uniform principles for evaluation and authorisation of plant protection products. OJ L 155, 11.6.2011, p. 127--175.

Commission Regulation (EU) 2016/486 of 29 March 2016 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for cyazofamid, cycloxydim, difluoroacetic acid, fenoxycarb, flumetralin, fluopicolide, flupyradifurone, fluxapyroxad, kresoxim‐methyl, mandestrobin, mepanipyrim, metalaxyl‐M, pendimethalin and tefluthrin in or on certain products. OJ L 90, 6.4.2016, p. 1--66.

[^1]: MRL: maximum residue level.

[^2]: \* MRL set at the limit of quantification (LOQ).

[^3]: a Commodity code number according to Annex I of Regulation (EC) No 396/2005.

[^4]: b Existing EU MRL and corresponding footnote on confirmatory data.

[^5]: c The residue definition in the Commission database does not correspond to the residue definitions specify for kresoxim‐methyl in Commission Regulation (EU) 2016/486.

[^6]: ft The European Food Safety Authority identified some information on storage stability as unavailable. When reviewing the MRL, the Commission will take into account the information referred to in the first sentence, if it is submitted by 23 July 2017, or, if that information is not submitted by that date, the lack of it. (Footnote related to data gap No 4).

[^7]: Storage stability has not been demonstrated for the following metabolite‐matrix combinations: BF 490‐9 in muscle, BF‐490‐2 in liver and BF 490‐91 in milk; however, it is not required considering that these metabolite‐matrix combinations are not expected according to the ruminant metabolism study.

[^8]: MRL: maximum residue level.

[^9]: \* MRL set at the limit of quantification (LOQ).

[^10]: a Commodity code number according to Annex I of Regulation (EC) No 396/2005.

[^11]: b Existing EU MRL and corresponding footnote on confirmatory data.

[^12]: c The residue definition in the Commission database does not correspond to the residue definitions specify for kresoxim‐methyl in Commission Regulation (EU) 2016/486.

[^13]: ft The European Food Safety Authority identified some information on storage stability as unavailable. When reviewing the MRL, the Commission will take into account the information referred to in the first sentence, if it is submitted by 23 July 2017, or, if that information is not submitted by that date, the lack of it. (Footnote related to data gap No 4).

[^14]: IUPAC: International Union of Pure and Applied Chemistry; SMILES: simplified molecular‐input line‐entry system; InChiKey: International Chemical Identifier Key.

[^15]: The metabolite name in bold is the name used in the conclusion.

[^16]: ACD/Name 2017.2.1 ACD/Labs 2017 Release (File version N40E41, Build 96719, 6 September 2017).

[^17]: ACD/ChemSketch 2017.2.1 ACD/Labs 2017 Release (File version C40H41, Build 99535, 14 February 2018).
